Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2018, Article ID 7017286, 4 pages
Case Report

Staphylococcus aureus Myocarditis with Associated Left Ventricular Apical Thrombus

1Cardiovascular Department, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW 2305, Australia
2Infectious Diseases Department, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW 2305, Australia
3Department of Medicine, University of Newcastle, Newcastle, NSW, Australia

Correspondence should be addressed to Michael McGee; moc.liamg@j.leahcim.eegcm

Received 7 April 2018; Accepted 16 May 2018; Published 23 May 2018

Academic Editor: Ertugrul Ercan

Copyright © 2018 Michael McGee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Staphylococcus aureus myocarditis is a rare diagnosis with a high mortality rate, usually seen in people who are immunocompromised. Here, we report a case of a 44-year-old man on methotrexate for rheumatoid arthritis who presented in septic shock and was diagnosed with staphylococcus aureus myocarditis. The myocarditis was associated with a left ventricular apical thrombus, with normal systolic function. The myocarditis and associated thrombus were characterised on transthoracic echocardiogram and subsequently on cardiac magnetic resonance imaging. Cardiac magnetic resonance (CMR) imaging showed oedema in the endomyocardium, consistent with acute myocarditis, associated with an apical mural thrombus. Repeat CMR 3 weeks following discharge from hospital showed marked improvement in endomyocardial oedema and complete resolution of the apical mural thrombus. He was treated with a 12-week course of antibiotics and anticoagulated with apixaban. The patient was successfully managed with intravenous antibiotics and anticoagulation with complete recovery.

1. Introduction

Staphylococcus aureus is widely reported to be the most common bacterial cause of myocarditis and usually occurs in the setting of bacteraemia and sepsis. Rarely, it occurs without associated infective endocarditis [1, 2]. Furthermore, difficulty in determining the diagnosis, prevalence, and aetiology of myocarditis is complicated by the infrequent use of endomyocardial biopsy (EMB), the diagnostic gold standard [2, 3].

Noninvasive imaging such as cardiac magnetic resonance (CMR) imaging has been shown to be reliable in the diagnosis and monitoring of disease progression in acute myocarditis [4, 5]. Despite the advances of noninvasive imaging, the sensitivity and specificity of CMR for acute myocarditis are reported at 81% and 71% and 63% and 40% in chronic myocarditis [6]. Ideally, CMR and EMB are both obtainable and are complimentary, overcoming limitations of either technique alone [4].

Here, we present a case of Staphylococcus aureus myocarditis with associated left ventricular apical thrombus.

2. Case History

A 44-year-old male was admitted to the intensive care unit (ICU) critically unwell with septic shock. On the day prior to admission, he had complained of lethargy, diffuse body aches, epigastric pain, nausea, and vomiting and had experienced rigors. He had a medical background significant for rheumatoid arthritis, treated with methotrexate 10 mg weekly for the last five years and had recently travelled to Fiji.

On arrival of paramedics, the patient was nonresponsive, febrile, and tachycardic, with an unrecordable blood pressure and mottled appearance of the skin. He was drowsy and confused on arrival to the emergency department and had prolonged capillary refill of five seconds, a lactate of 6.8. There was no clear focus of infection on examination, and cardiovascular examination was normal at this time. He was found to have an acute kidney injury, hepatic impairment, and coagulopathy, see Table 1. Blood cultures returned positive in 11 hours for methicillin-sensitive Staphylococcus aureus, and antibiotics were changed to intravenous (IV) flucloxacillin. He was culture positive for 48 hours.

Table 1: Blood work on presentation to hospital and peak values.

His course was further complicated by development of left olecranon bursitis, treated by open drainage. The bursitis was culture negative but presumed septic. He also had several episodes of atypical chest pain. Electrocardiogram at the time of pain revealed sinus tachycardia, with lateral T wave inversion, and high-sensitivity troponin was elevated at 139 ng/L (NR < 26 ng/L). Transthoracic echocardiogram revealed normal left ventricular systolic function, with an echo-dense mass in the apex, no valvular abnormality, and mild left atrial dilatation. The patient proceeded to cardiac magnetic resonance (CMR) imaging which showed increased wall thickness in the mid to apical wall segments and high signal intensity in the mid to apical endocardium on short tau inversion recovery (STIR) imaging. There was late gadolinium enhancement in the same area, consistent with oedema in the apical endomyocardium (Figure 1). There was also a nonenhancing mass in the left ventricular apex consistent with thrombus and small bilateral pleural effusions (Figure 2).

Figure 1: Cardiac magnetic resonance imaging 4-chamber-view post gadolinium injection revealing late gadolinium enhancement of the endomyocardium at the left ventricular apex.
Figure 2: Cardiac magnetic resonance imaging 4-chamber view (still frame from a steady-state free precession (SSFP) cine sequence) with the left ventricular apical mass taken shortly after presentation.

Anticoagulation with therapeutic dose enoxaparin was commenced, which was subsequently changed to apixaban 5 mg twice daily prior to discharge.

A repeat echocardiogram was performed 10 days after the initial echocardiogram, which did not reveal any interval change. The patient was discharged with IV flucloxacillin to continue via a peripherally inserted central catheter (PICC) line and ongoing anticoagulation with apixaban. Repeat CMR was performed 3 weeks following discharge and revealed normal left ventricular cavity size, with mildly increased wall thickness in the mid to apical wall segments. Tissue characterisation was consistent with apical wall oedema, which had reduced significantly in size since the previous CMR, and complete resolution of the left ventricular apical mural thrombus and pleural effusions (Figure 3). He completed a 6-week course of IV flucloxacillin, followed by a 6-week course of oral dicloxacillin, and remained clinically well throughout this time.

Figure 3: Cardiac magnetic resonance imaging 4-chamber view (still frame from a steady-state free precession (SSFP) cine sequence) taken 3 weeks after the previous study and on treatment (apixaban and antibiotics) demonstrating resolution of the apical mass.

3. Discussion

The majority of published cases of bacterial myocarditis are autopsy studies and predate the use of antibiotics [1]. Flaxman in 1943 described 17 cases of staphylococcal myocardial abscesses without endocarditis [7]. Sanders in 1963 reported nine similar cases [8]. A further seven cases of staphylococcal myocarditis have been reported, six of which died with diagnosis confirmed at autopsy [914]. One case had aortic valve insufficiency requiring valve replacement secondary to a massive intramyocardial abscess [15]. All cases developed septic shock as a result of staphylococcal bacteraemia, and one case died as a result of ventricular rupture [10]. Risk factors for infection were identified in four cases including end-stage renal disease on haemodialysis [12], steroid-dependent Crohn’s disease, and initiation of infliximab [15] and two cases with AIDS [13].

This case demonstrates two aspects of myocarditis that are unusual: firstly, isolated staphylococcus aureus myocarditis with no evidence of valvular involvement and secondly, left ventricular apical thrombus formation in a patient with normal left ventricle systolic function.

Isolated staphylococcus aureus myocarditis remains a rare condition. There have been case reports of both methicillin-sensitive and methicillin-resistant infections. As distinct from endocarditis and device infections, these cases of myocarditis are almost exclusively described in individuals who are immunocompromised.

Several conditions can present with thrombus or thrombus-like formation in the left ventricular apex, including dilated cardiomyopathy, Loeffler’s endocarditis, myxoma, Chagas disease, and aneurysms. Factors that influence thrombus formation include blood stagnation, endothelial injury, and hypercoagulable states [16, 17].

In this case, the predominant force of Virchow’s triad is likely endothelial injury and inflammation secondary to myocarditis. Echocardiography demonstrated the apical mass but was not able to define the thrombus or associated inflammation in the myocardium, whereas CMR was useful for tissue characterisation but not able to identify the aetiology.

Anticoagulation in cases of left ventricular thrombus, especially in the context of normal systolic function, has limited evidence but is used to reduce the risk of embolisation. Warfarin has historically been used due to familiarity and lack of evidence with direct acting oral anticoagulants (DOACs). Several cases of successful treatment with DOACs have been described [18], but to our knowledge, this is the first case of thrombus treatment with apixaban in the context of normal systolic function.

Conflicts of Interest

There are no conflicts of interest to disclose for any of the authors.


  1. F. Wasi and J. Shuter, “Primary bacterial infection of the myocardium,” Frontiers in Bioscience, vol. 8, pp. s228–s231, 2003. View at Publisher · View at Google Scholar
  2. A. L. P. Caforio, S. Pankuweit, E. Arbustini et al., “Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases,” European Heart Journal, vol. 34, no. 33, pp. 2636–2648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Leone, J. P. Veinot, A. Angelini et al., “2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology,” Cardiovascular Pathology, vol. 21, no. 4, pp. 245–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Baccouche, H. Mahrholdt, G. Meinhardt et al., “Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease,” European Heart Journal, vol. 30, no. 23, pp. 2869–2879, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Gutberlet, B. Spors, T. Thoma et al., “Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence,” Radiology, vol. 246, no. 2, pp. 401–409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Lurz, I. Eitel, J. Adam et al., “Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis,” JACC: Cardiovascular Imaging, vol. 5, no. 5, pp. 513–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Flaxman, “Myocardial Abscess,” JAMA, vol. 122, no. 12, pp. 804–806, 1943. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Sanders, “Viral myocarditis,” American Heart Journal, vol. 66, no. 5, pp. 707–713, 1963. View at Publisher · View at Google Scholar · View at Scopus
  9. A. K. Sikary, A. R. Mridha, and C. Behera, “Sudden death of a child due to pyogenic bacterial myocarditis,” Medico-Legal Journal, vol. 85, no. 2, pp. 105–107, 2017. View at Publisher · View at Google Scholar
  10. R. M. LeLeiko, D. J. Bower, and C. P. Larsen, “MRSA-associated bacterial myocarditis causing ruptured ventricle and tamponade,” Cardiology, vol. 111, no. 3, pp. 188–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. P. Lee, W. H. Hoi, and R. C. Wong, “A case of myopericarditis in a patient with methicillin-resistant Staphylococcus aureus community-acquired pneumonia,” Annals of the Academy of Medicine, Singapore, vol. 37, no. 3, pp. 243–242, 2008. View at Google Scholar
  12. B. Khan, R. W. Strate, and R. Hellman, “ASDIN Original Investigations: Myocardial abscess and fatal cardiac arrhythmia in a hemodialysis patient with an arterio-venous fistula infection,” Seminars in Dialysis, vol. 20, no. 5, pp. 452–454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Hofman, J. F. Michiels, E. Rosenthal et al., “Acute Staphylococcus aureus myocarditis in AIDS. 2 cases,” Archives des Maladies du Coeur et des Vaisseaux, vol. 86, no. 12, pp. 1765–1768, 1993. View at Google Scholar
  14. P. Jariwala, A. Punjani, S. Mirza, B. Harikishan, and D. B. Madhawar, “Myocardial abscess secondary to staphylococcal septicemia: diagnosis with 3D echocardiography,” Indian Heart Journal, vol. 65, no. 1, pp. 124-125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Reichardt, I. Dahnert, G. Tiller, and H. J. Hausler, “Possible activation of an intramyocardial inflammatory process (Staphylococcus aureus) after treatment with infliximab in a boy with Crohn disease,” European Journal of Pediatrics, vol. 161, no. 5, pp. 281–283, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Delewi, F. Zijlstra, and J. J. Piek, “Left ventricular thrombus formation after acute myocardial infarction,” Heart, vol. 98, no. 23, pp. 1743–1749, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Solheim, I. Seljeflot, K. Lunde et al., “Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy,” Thrombosis Journal, vol. 11, no. 1, p. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Mano, K. Koide, H. Sukegawa, M. Kodaira, and T. Ohki, “Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction,” Heart and Vessels, vol. 31, no. 1, pp. 118–123, 2016. View at Publisher · View at Google Scholar · View at Scopus